Showing results (211-220 of 317) with videos related to
Sort By:
Pageof 32
American Journal of Hematology|September 25, 2025
Validation of BLAST and BLAST-Mol Risk Models in Chronic Myelomonocytic Leukemia: Mayo-Humanitas Collaborative Project Involving 1101 PatientsSaubia Fathima, Ali Alsugair, Muhammad Yousuf, et al.Blood Advances|April 2, 2024
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significanceMarissa Li, Anmol Baranwal, Mark Gurney, et al.American Journal of Hematology|April 12, 2021
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive casesNaseema Gangat, Paola Guglielmelli, Natasha Szuber, et al.Blood Cancer Journal|September 22, 2023
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneityTalha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, et al.Mayo Clinic Proceedings|November 8, 2015
Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 PatientsNaseema Gangat, Mrinal M Patnaik, Kebede Begna, et al.Blood Cancer Journal|July 8, 2022
Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasmsMithun Vinod Shah, Abhishek A Mangaonkar, Kebede H Begna, et al.British Journal of Haematology|February 4, 2024
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agentsIsla M Johnson, Omer Karrar, Masooma Rana, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 10, 2015
Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patientsD J Wojenski, G T Bartoo, J A Merten, et al.Haematologica|December 4, 2025
Inherited DNA repair variants are associated with clonal hematopoiesis and cardiovascular risk in men with metastatic prostate cancerOlisaemeka Ogbue, Yael Kusne, Osama Mosalem, et al.British Journal of Haematology|March 5, 2025
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndromeYael Kusne, Talha Badar, Terra Lasho, et al.Pageof 32